Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,018 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
Nakanishi R, Oki E, Hasuda H, Sano E, Miyashita Y, Sakai A, Koga N, Kuriyama N, Nonaka K, Fujimoto Y, Jogo T, Hokonohara K, Hu Q, Hisamatsu Y, Ando K, Kimura Y, Yoshizumi T, Mori M. Nakanishi R, et al. Among authors: nonaka k. Ann Surg Oncol. 2021 Jun;28(6):2975-2985. doi: 10.1245/s10434-020-09581-5. Epub 2021 Jan 16. Ann Surg Oncol. 2021. PMID: 33454878
ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
Nakanishi R, Oki E, Hasuda H, Sano E, Miyashita Y, Sakai A, Koga N, Kuriyama N, Nonaka K, Fujimoto Y, Jogo T, Hokonohara K, Hu Q, Hisamatsu Y, Ando K, Kimura Y, Yoshizumi T, Mori M. Nakanishi R, et al. Among authors: nonaka k. Ann Surg Oncol. 2021 Jun;28(6):2986-2987. doi: 10.1245/s10434-020-09584-2. Epub 2021 Mar 16. Ann Surg Oncol. 2021. PMID: 33725205 No abstract available.
Artificial Intelligence-Based Prediction of Recurrence after Curative Resection for Colorectal Cancer from Digital Pathological Images.
Nakanishi R, Morooka K, Omori K, Toyota S, Tanaka Y, Hasuda H, Koga N, Nonaka K, Hu Q, Nakaji Y, Nakanoko T, Ando K, Ota M, Kimura Y, Oki E, Oda Y, Yoshizumi T. Nakanishi R, et al. Among authors: nonaka k. Ann Surg Oncol. 2023 Jun;30(6):3506-3514. doi: 10.1245/s10434-022-12926-x. Epub 2022 Dec 13. Ann Surg Oncol. 2023. PMID: 36512260
[No title available]
[No authors listed] [No authors listed] PMID: 36592258
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.
Maehara Y, Oki E, Ota M, Harimoto N, Ando K, Nakanishi R, Kawazoe T, Fujimoto Y, Nonaka K, Kitao H, Iimori M, Makino K, Takechi T, Sagara T, Miyadera K, Matsuoka K, Tsukihara H, Kataoka Y, Wakasa T, Ochiiwa H, Kamahori Y, Tokunaga E, Saeki H, Yoshizumi T, Kakeji Y, Shirabe K, Baba H, Shimada M. Maehara Y, et al. Among authors: nonaka k. Int J Clin Oncol. 2023 May;28(5):613-624. doi: 10.1007/s10147-023-02326-w. Epub 2023 Mar 24. Int J Clin Oncol. 2023. PMID: 36961615
A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report.
Ikeda S, Hu Q, Natsugoe K, Harima T, Tanaka Y, Kinoshita I, Nonaka K, Nambara S, Nakanishi R, Nakanoko T, Ota M, Kimura Y, Oki E, Oda Y, Yoshizumi T. Ikeda S, et al. Among authors: nonaka k. Int Cancer Conf J. 2023 Jul 26;12(4):279-284. doi: 10.1007/s13691-023-00622-w. eCollection 2023 Oct. Int Cancer Conf J. 2023. PMID: 37577343 Free PMC article.
1,018 results